What's Happening?
Peri, a women's health and data company, has launched the first wearable device specifically designed for perimenopause. The device provides continuous biometric tracking, offering women insights into their symptoms and health over time. Priced at $449,
the device is FSA and HSA-eligible. Peri's CEO, Heidi Davis, emphasized the importance of providing women with objective data to make informed health decisions. The device aims to reshape treatment development and clinical decisions in a historically under-researched area of women's health.
Why It's Important?
Peri's wearable device represents a significant advancement in women's health, particularly in understanding and managing perimenopause. By providing real-time data, the device empowers women to take control of their health and advocate for themselves in a healthcare system that has often overlooked their needs. The large-scale dataset collected by Peri could lead to improved treatments and healthcare practices, addressing a critical gap in women's health research.
